Latest Crealta Pharmaceuticals LLC Stories
New review outlines the data supporting the relationship between urate-lowering efficacy and the risk for infusion reactions with Krystexxa® (pegloticase), the only FDA-approved treatment for chronic
Acquisition is highlighted by KRYSTEXXA® (pegloticase), the only product approved for the treatment of refractory chronic gout GLENDALE, Wis., Jan.
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.